BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
2.600
+0.100 (4.00%)
Oct 8, 2025, 10:00 AM EDT - Market open
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $51.08 million as of October 8, 2025. Its market cap has increased by 117.44% in one year.
Market Cap
51.08M
Enterprise Value
140.62M
1-Year Change
117.44%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $51.08M, a decrease of -70.40%. That is a compound annual growth rate of -14.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 49.12M | 164.69% |
| Dec 31, 2024 | 18.56M | -78.51% |
| Dec 29, 2023 | 86.35M | -85.65% |
| Dec 30, 2022 | 601.94M | 5.82% |
| Dec 31, 2021 | 568.84M | -49.47% |
| Dec 31, 2020 | 1.13B | 327.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.98B |
| Johnson & Johnson | 452.19B |
| AbbVie | 404.88B |
| UnitedHealth Group | 324.89B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.68B |